Ohio-based Ben Venue specializes in sterile products--development and manufacture of liquid and lyophilized drugs. Its Bedford Labs unit focuses on critical-care and medically necessary generic injectables.
Ben Venue boasts proficiency in contract lyophilization and vacuum-drying of parenterals. It can provide materials from pre-IND through NDA submission.
Services include dosage form development, clinical manufacturing and commercial scale production for small molecule, biologics, cytotoxics and potent compounds.
Nice rates Ben Venue a 77% CP score in Q3, down two points from the previous quarter, but up 19 points from Q1.
Editor's Note: Ben Venue made known in August that it is exiting the CMO business. The group will not appear on any of our future lists of top CMOs.